Home Health Nigeria registers 2,401 new medicines, 190 local manufacturing companies in three years,...

Nigeria registers 2,401 new medicines, 190 local manufacturing companies in three years, earns WHO commendation

158
0
Dr Pavel Ursu, WHO Country Representative to Nigeria met with Professor Mojisola Adeyeye of NAFDAC, recently
Access Pensions, Future Shaping

By theG&BJournal

WHO and NAFDAC officials in meeting in Abuja

THUR FEB 26 2026-theGBJournal| Nigeria’s pharmaceutical landscape has recorded a significant leap forward, with 2,401 new medicine products registered, including 190 of registered local manufacturing companies between January 2023 and December 2025.

The milestone has drawn commendation from the World Health Organization (WHO), which described the development as a strong signal of Nigeria’s strengthening regulatory framework and commitment to global best practices.

It also underscores growing national production, stronger regulatory performance, and improved availability of health products for the population.

The milestone was revealed on Wednesday when Dr Pavel Ursu, World Health Organization (WHO) Country Representative to Nigeria met with Professor Mojisola Adeyeye of National Agency for Food and Drug Administration and Control (NAFDAC) to reinforce Nigeria’s steady progress toward ensuring every community can access quality-assured essential medicines and diagnostics.

According to the WHO representative, Nigeria’s sustained achievement of WHO Global Benchmarking Maturity Level 3 for medicines is a major milestone.

The recognition comes amid broader reforms aimed at enhancing pharmacovigilance, quality assurance and supply chain transparency across Africa’s most populous nation.

The achievement marks one of the most productive approval cycles in recent years, reflecting intensified reforms in the country’s drug administration system.

The registrations, overseen by NAFDAC, span a wide range of therapeutic categories including antibiotics, antimalarials, antihypertensives, vaccines and specialized treatments.

Officials say the approvals align with efforts to improve medicine availability, promote local manufacturing and curb the circulation of substandard or counterfeit drugs.

Health sector stakeholders believe the surge in registered products could boost investor confidence in Nigeria’s pharmaceutical market, deepen partnerships with international manufacturers and improve patient outcomes.

However, experts also stress that sustained monitoring, enforcement and support for domestic producers will be critical to ensuring that quantity translates into quality and affordability for millions of Nigerians.

X-@theGBJournal|Facebook-the Government and Business Journal|email:gbj@govbusinessjournal.com|govandbusinessj@gmail.com

 

 

 

 

 

Access Pensions, Future Shaping
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments